Movement Disorders Centre

It is supported by funding from University College London Hospitals and the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC). The centre is part of the Department of Clinical and Movement Neurosciences at the UCL Queen Square Institute of Neurology, which undertakes world-leading basic and clinical research across the spectrum of movement disorders, their causes, and treatments. The MDC is a hub for clinical and research excellence across a range of movement disorders, including Parkinson’s, atypical parkinsonism, dystonia, rare movement disorders, and other related conditions. Our group of world-leading clinical, genetic, and biochemical researchers work to uncover the causes and biological mechanisms behind movement disorders and develop new treatments. The centre brings together patients, clinicians, data, discovery research programmes, and experimental medicine trials to make key breakthroughs in movement disorders. Through world-class research, we aim to better understand the causes, effects, biological mechanisms, and treatment of these conditions. The MDC also supports the delivery and development of clinical services for movement disorder patients across our affiliated hospitals: University College London Hospital (UCLH), National Hospital for Neurology and Neurosurgery (NHNN) at Queen Square, and The Royal Free Hospital.